The EARTH (Early Anti-Retroviral Treatment in HIV- infected Children) cohort includes 215 participants from 5 African sites, followed with a follow up of up to 4 years.
It has been established by the Consortium with the aim to identify early-treated children which are more likely to benefit from novel therapeutic interventions, including NDMTs.
215 participants have been enrolled at all sites and are being followed for up to 4 years.